Future Rheumatol. 2008;3(2):153-159. Although VEGF seems to be a good target for RA, some of the side effects observed with anti-VEGF treatments have led to suggestion that other angiogenic factors ...
Angiogenesis plays a central role in RA. Serum angiogenesis-marker levels are associated with RA severity and progression. Although their lack of specificity makes them unsuitable for diagnostic ...